Search

Your search keyword '"Zhou, Betty Y."' showing total 11 results
Start Over Author "Zhou, Betty Y."
11 results on '"Zhou, Betty Y."'

10. Protection against Human Immunodeficiency Virus Type 1 Tat Neurotoxicity by Ginkgo bilobaExtract EGb 761 Involving Glial Fibrillary Acidic Protein

Author

Zou, Wei, Kim, Byung Oh, Zhou, Betty Y., Liu, Ying, Messing, Albee, and He, Johnny J.

Abstract

Human immunodeficiency virus (HIV)-1 Tat protein is an important pathogenic factor in HIV-associated neuropathogenesis. Despite recent progress, the molecular mechanisms underlying Tat neurotoxicity are still not completely understood. However, few therapeutics have been developed to specifically target HIV infection in the brain. Recent development of an inducible brain-specific Tat transgenic mouse model has made it possible to define the mechanisms of Tat neurotoxicity and evaluate anti-neuroAIDS therapeutic candidates in the context of a whole organism. Herein, we demonstrate that administration of EGb 761, a standardized formulation of Ginkgo bilobaextract, markedly protected Tat transgenic mice from Tat-induced developmental retardation, inflammation, death, astrocytosis, and neuron loss. EGb 761 directly down-regulated glial fibrillary acidic protein (GFAP) expression at both protein and mRNA levels. This down-regulation was, at least in part, attributable to direct effects of EGb 761 on the interactions of the AP1 and NF-κB transcription factors with the GFAP promoter. Most strikingly, Tat-induced neuropathological phenotypes including macrophage/microglia activation, central nervous system infiltration of T lymphocytes, and oxidative stress were significantly alleviated in GFAP-null/Tat transgenic mice. Taken together, these results provide the first evidence to support the potential for clinical use of EGb 761 to treat HIV-associated neurological diseases. Moreover, these findings suggest for the first time that GFAP activation is directly involved in Tat neurotoxicity, supporting the notion that astrocyte activation or astrocytosis may directly contribute to HIV-associated neurological disorders.

Published
2007
Full Text
View/download PDF

11. Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein.

Author

Kim BO, Liu Y, Zhou BY, and He JJ

Subjects
Amino Acid Motifs, Animals, Astrocytes immunology, Astrocytes metabolism, Brain cytology, Brain immunology, Brain metabolism, Brain virology, Cell Line, Tumor, Cells, Cultured, Chemokines, C chemistry, Chemokines, C genetics, Gene Expression Regulation, Gene Products, tat biosynthesis, Gene Products, tat genetics, HIV-1 genetics, Humans, Lymphocyte Activation, Lymphokines chemistry, Macrophages immunology, Macrophages metabolism, Mice, Mice, Transgenic, Microglia immunology, Microglia metabolism, Monocytes immunology, Monocytes metabolism, Promoter Regions, Genetic, RNA, Messenger biosynthesis, Sialoglycoproteins chemistry, Up-Regulation genetics, tat Gene Products, Human Immunodeficiency Virus, Chemokines, C biosynthesis, Gene Products, tat physiology, HIV-1 physiology, T-Lymphocytes immunology, T-Lymphocytes metabolism
Abstract

HIV-1 Tat has been proposed as a key agent in many AIDS-related disorders, including HIV-1-associated neurological diseases. We have recently shown that Tat expression induces a significant increase in T lymphocytes in the brains of Tat transgenic mice. The CNS infiltration of T lymphocytes has been noted in AIDS patients. In the present study using this unique genetic system we attempted to understand the underlying mechanisms of Tat expression-induced infiltration of T lymphocytes by examining chemokine expression. RNase protection assay revealed that in addition to CCL2 (monocyte chemoattractant protein-1), CCL3 (macrophage inflammatory protein-1alpha (MIP-1alpha)), CCL4 (MIP-1beta), CCL5 (RANTES), CXCL2 (MIP-2), and CXCL10 (inducing protein-10), XCL1 (lymphotactin/single C motif-1alpha/activation-induced, T cell-derived and chemokine-related cytokine) was identified to be up-regulated by Tat expression. XCL1 is a C chemokine and plays a specific and important role in tissue-specific recruitment of T lymphocytes. Thus, we further determined the relationship between Tat and XCL1 expression. Tat-induced XCL1 expression was further confirmed by XCL1-specific RT-PCR and ELISA. Combined in situ hybridization and immunohistochemical staining identified astrocytes, monocytes, and macrophages/microglia as XCL1-producing cells in vivo. Using human astrocytes, U87.MG cells, as an in vitro model, activation of XCL1 expression was positively correlated with Tat expression. Moreover, the XCL1 promoter-driven reporter gene assay showed that Tat-induced XCL1 expression occurred at the transcriptional level. Taken together, these results demonstrate that Tat directly trans-activated XCL1 expression and suggest potential roles of Tat-induced XCL1 expression in the CNS infiltration of T lymphocytes during HIV-1 infection and subsequent HIV-1-induced neurological diseases.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results